Spinal Muscular Atrophy: New and Emerging Insights from Model Mice

被引:44
|
作者
Park, Gyu-Hwan [1 ,3 ]
Kariya, Shingo [1 ,3 ]
Monani, Umrao R. [1 ,2 ,3 ]
机构
[1] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA
[3] Columbia Univ, Med Ctr, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA
关键词
Survival motor neuron; Spinal muscular atrophy; Mouse models; Neurodegeneration; MOTOR-NEURON PROTEIN; DISEASE GENE-PRODUCT; MOUSE MODEL; MISSENSE MUTATION; NEUROMUSCULAR-JUNCTIONS; WALLERIAN DEGENERATION; VALPROIC ACID; SMN PROTEIN; SURVIVAL; SEVERITY;
D O I
10.1007/s11910-010-0095-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal muscular atrophy (SMA) is a common and often fatal neurodegenerative disease that primarily afflicts infants and young children. SMA is caused by abnormally low levels of the survival motor neuron (SMN) protein resulting from a combination of recessively inherited mutations in the SMN1 gene and the presence of an almost identical but partially functional copy gene, SMN2. Absence of the uniquely human SMN2 gene in SMA patients has never been reported because the SMN protein is indispensable for cell survival. Modeling SMA in animals therefore poses a challenge. This review describes the different strategies used to overcome this hurdle and model SMA in mice. We highlight new and emerging insights regarding SMA gained by studying the mice and illustrate how the animals serve as important tools to understand and eventually treat the human disease.
引用
收藏
页码:108 / 117
页数:10
相关论文
共 50 条
  • [31] Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice
    Tsai, Li-Kai
    Tsai, Ming-Shiun
    Ting, Chen-Hung
    Li, Hung
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (11): : 1243 - 1254
  • [32] Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice
    Li-Kai Tsai
    Ming-Shiun Tsai
    Chen-Hung Ting
    Hung Li
    Journal of Molecular Medicine, 2008, 86 : 1243 - 1254
  • [33] Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice
    de la Fuente, Sandra
    Sansa, Alba
    Periyakaruppiah, Ambika
    Garcera, Ana
    Soler, Rosa M.
    MOLECULAR NEUROBIOLOGY, 2019, 56 (06) : 4414 - 4427
  • [34] Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy
    Gogliotti, Rocky G.
    Hammond, Suzan M.
    Lutz, Cathleen
    DiDonato, Christine J.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 517 - 522
  • [35] Investigational therapies for the treatment of spinal muscular atrophy
    Kaczmarek, Anna
    Schneider, Svenja
    Wirth, Brunhilde
    Riessland, Markus
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 867 - 881
  • [36] Advances and limitations for the treatment of spinal muscular atrophy
    Day, John W.
    Howell, Kelly
    Place, Amy
    Long, Kimberly
    Rossello, Jose
    Kertesz, Nathalie
    Nomikos, George
    BMC PEDIATRICS, 2022, 22 (01)
  • [37] Advances in modeling and treating spinal muscular atrophy
    Van Alstyne, Meaghan
    Pellizzoni, Livio
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (05) : 549 - 556
  • [38] Perspectives and diagnostic considerations in spinal muscular atrophy
    Prior, Thomas W.
    GENETICS IN MEDICINE, 2010, 12 (03) : 145 - 152
  • [39] miRNA in spinal muscular atrophy pathogenesis and therapy
    Magri, Francesca
    Vanoli, Fiammetta
    Corti, Stefania
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (02) : 755 - 767
  • [40] Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
    Giorgia, Querin
    de la Banda, Marta Gomez Garcia
    Smeriglio, Piera
    FRONTIERS IN NEUROLOGY, 2023, 14